You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CD34 selected progenitors cell

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

AML, ALL, Lymphoid Malignancies Trial in Birmingham (Infusion of CD34 selected hematopoietic stem cells)

Not yet recruiting
  • AML
  • +5 more
  • Infusion of CD34 selected hematopoietic stem cells
  • Birmingham, Alabama
    University of Alabama at Birmingham
Sep 14, 2023

Severe Aplastic Anemia, MDS (Myelodysplastic Syndrome) Trial in Baltimore, Bethesda, Minneapolis (Miltenyi CD34 Reagent System,

Recruiting
  • Severe Aplastic Anemia
  • MDS (Myelodysplastic Syndrome)
  • Miltenyi CD34 Reagent System
  • Donor derived G-CSF mobilized PBC
  • Baltimore, Maryland
  • +2 more
Jan 25, 2023

Acute Myeloid Leukemia Trial in Miami (CPX-351, Midostaurin, Busulfan)

Recruiting
  • Acute Myeloid Leukemia
  • Miami, Florida
    Miami Cancer Institute at Baptist Health of South Florida
Jul 27, 2022

Sickle Cell Disease Trial in Paris (DREPAGLOBE drug product)

Active, not recruiting
  • Sickle Cell Disease
  • DREPAGLOBE drug product
  • Paris, France
    Department of Biotherapy, Necker-Enfants Malades Hospital
Sep 26, 2022

Malignant Non-Hodgkin Lymphomas Trial in Berne (CD34+ cell selection)

Active, not recruiting
  • Malignant Non-Hodgkin Lymphomas
  • CD34+ cell selection
  • Berne, Switzerland
    Department for Medical Oncology; University Hospital/Inselspital
Jul 29, 2021

Hematologic Disorders Trial in Aurora (Miltenyi CliniMACS® CD34 Reagent System)

Recruiting
  • Hematologic Disorders
  • Miltenyi CliniMACS® CD34 Reagent System
  • Aurora, Colorado
    University of Colorado
Feb 22, 2022

Chronic Myeloid Leukemia, Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in Atlanta (G-CSF mobilized CD34+ selected

No longer available
  • Chronic Myeloid Leukemia
  • +2 more
  • G-CSF mobilized CD34+ selected cells for transplantation
  • Atlanta, Georgia
    Emory University/Winship Cancer Institute
Feb 28, 2022

Crohn's Disease Trial in Pittsburgh (autologous CD34-selected peripheral blood stem cells transplant, Alemtuzumab, ATG)

Recruiting
  • Crohn's Disease
  • autologous CD34-selected peripheral blood stem cells transplant
  • +8 more
  • Pittsburgh, Pennsylvania
  • +1 more
Feb 9, 2022

B-cell Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Charleston (Cyclophosphamide injection, Fludarabine

Not yet recruiting
  • B-cell Non Hodgkin Lymphoma
  • Chronic Lymphocytic Leukemia
  • Cyclophosphamide injection
  • +2 more
  • Charleston, South Carolina
    Hollings Cancer Center at Medical University of South Carolina
Jan 18, 2023

Benign Tumor, Bone Marrow Transplantation Recipient, Hematopoietic Cell Transplantation Recipient Trial in Portland (Bone Marrow

Available
  • Benign Neoplasm
  • +3 more
  • Bone Marrow Transplantation
  • +2 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Dec 9, 2021

MDS, Graft Vs Host Disease, Graft-versus-host-disease Trial in Miami (Busulfan, Melphalan, Fludarabine)

Not yet recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Miami, Florida
    Miami Cancer Institute
Jan 10, 2023

Scleroderma, Cardiac Involvement, Autologous Stem Cell Transplantation Trial in Tuebingen (Autologous stemcell transplantation

Active, not recruiting
  • Scleroderma
  • +2 more
  • Autologous stemcell transplantation with CD (cluster of differentiation) 34 selected stem cells
  • Tuebingen, Germany
    University Hospital Tuebingen; Department of oncology, hematolog
May 16, 2022

Lymphoma, Peripheral Blood Stem Cell Transplantation Trial (Eltrombopag olamine)

Not yet recruiting
  • Lymphoma
  • Peripheral Blood Stem Cell Transplantation
  • Eltrombopag olamine
  • (no location specified)
Jul 25, 2023

Retinitis Pigmentosa Trial in Sacramento (Intravitreal autologous CD34+ cells)

Recruiting
  • Retinitis Pigmentosa
  • Intravitreal autologous CD34+ cells
  • Sacramento, California
    University of California Davis
Sep 1, 2022

Sickle Cell Disease Trial in United States (CD34 selected T-cell depleted allogeneic SCT)

Active, not recruiting
  • Sickle Cell Disease
  • CD34 selected T-cell depleted allogeneic SCT
  • Los Angeles, California
  • +5 more
Sep 27, 2022

Metastatic Non-Small Cell Lung Carcinoma Trial in Seoul (Pembrolizumab Injection)

Recruiting
  • Metastatic Non-Small Cell Lung Carcinoma
  • Pembrolizumab Injection
  • Seoul, Korea, Republic of
    Samsung Medical Center
Nov 6, 2022

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, MDS Trial in Stanford (CD8+ Memory T Cell Infusion, Thiotepa, Fludarabine)

Suspended
  • Acute Myeloid Leukemia
  • +4 more
  • CD8+ Memory T Cell Infusion
  • +5 more
  • Stanford, California
    Stanford Medical Center
Sep 23, 2021

Heart Failure, Mechanical Circulatory Support Trial in Ljubljana (CD34+ stem cell therapy)

Recruiting
  • Heart Failure
  • Mechanical Circulatory Support
  • CD34+ stem cell therapy
  • Ljubljana, Slovenia
    University Medical Center Ljubljana
Nov 22, 2023

Sickle Cell Disease Trial in Birmingham, Palo Alto, Saint Louis (GPH101 Drug Product)

Active, not recruiting
  • Sickle Cell Disease
  • GPH101 Drug Product
  • Birmingham, Alabama
  • +2 more
Jan 5, 2023

Sickle Cell Disease Trial in Saint Louis (Motixafortide, Natalizumab, Leukapheresis)

Not yet recruiting
  • Sickle Cell Disease
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 8, 2022

Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute Trial in Miami (Total Body Irradiation (TBI), Thiotepa, Cyclophosphamide)

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • Leukemia, Lymphocytic, Acute
  • Total Body Irradiation (TBI)
  • +5 more
  • Miami, Florida
    Baptist Health South Florida/Miami Cancer Institute
Nov 28, 2022

Hematologic Diseases, Hematologic Malignancy, Acute Lymphoblastic Leukemia Trial in Miami (device, procedure, drug)

Withdrawn
  • Hematologic Diseases
  • +5 more
  • CliniMACS
  • +7 more
  • Miami, Florida
    Miami Cancer Institute at Baptist Health, Inc.
Sep 26, 2022

Immunodeficiency Trial in Charlotte (Infusion of donor lymphocytes)

Terminated
Has Results
  • Immunodeficiency
  • Infusion of donor lymphocytes
  • Charlotte, North Carolina
    Levine Children's Hospital, Carolinas Medical Center
Apr 20, 2022

Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma Trial in United States (P-CD19CD20-ALLO1, Rimiducid)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • +5 more
  • La Jolla, California
  • +7 more
Aug 25, 2023

B-Cell Acute Lymphoblastic Leukemia, Adult, B-cell Lymphoma Refractory, B-cell Lymphoma Recurrent Trial in Maywood (Fludarabine,

Active, not recruiting
  • B-Cell Acute Lymphoblastic Leukemia, Adult
  • +2 more
  • Maywood, Illinois
    Loyola University
Aug 11, 2022